GlassScriptPhysician profile
Timothy B Brown
NPI 1942521125
$6,305.60
in general payments reported to CMS, 2019-2025
24 companies · $508 in 2025
The $508 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $535 · 2020: $606 · 2021: $413 · 2022: $2,126 · 2023: $1,849 · 2024: $267 · 2025: $508.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,550 · Travel and Lodging: $1,010 · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,549.92 |
| Travel and Lodging | $1,009.71 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,642.39 | 2019-2023 | Spaceoar Vue System - 10ml, Lithoclast |
| Astellas Pharma US INC | $613.89 | 2019-2023 | Myrbetriq |
| Medtronic, INC. | $367.23 | 2022-2025 | |
| Procept Biorobotics Corporation | $230.88 | 2022 | |
| Convatec INC. | $219.91 | 2022-2024 | |
| Teleflex LLC | $172.75 | 2021 | |
| Abbvie INC. | $167.07 | 2019-2024 | Botox |
| Endo Pharmaceuticals INC. | $160.41 | 2021-2024 | Xiaflex, Aveed |
| Srs Medical Systems, INC. | $146.22 | 2025 | Ct3000 Pro Base Unit, Urocuff-Dc Disposable, Single |
| Seagen INC. | $110.89 | 2023 | Padcev |
| Ferring Pharmaceuticals INC. | $67.68 | 2019-2024 | Adstiladrin |
| Telix Pharmaceuticals | $50.81 | 2023-2024 | Illuccix |
| Allergan, INC. | $49.35 | 2019-2020 | |
| Urovant Sciences INC | $45.88 | 2022 | |
| Janssen Biotech, INC. | $37.73 | 2019-2020 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Photocure INC | $32.89 | 2019-2025 | Cysview |
| Dentsply Ih Ab | $31.69 | 2024 | Lofric |
| 180 Medical, INC. | $29.83 | 2023 | Gentlecath |
| Merck Sharp & Dohme LLC | $28.00 | 2023 | Keytruda, Lynparza |
| Palette Life Sciences, INC. | $25.80 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $23.90 | 2021 | |
| Myriad Genetic Laboratories, INC. | $23.80 | 2021 | |
| Coloplast Corp | $13.43 | 2021 | |
| Neotract INC. | $13.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.